{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:28:50Z","timestamp":1787236130328,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T00:00:00Z","timestamp":1512950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T00:00:00Z","timestamp":1512950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The activities of osteoclasts and osteoblasts are balanced to maintain normal bone density. Many pathological conditions cause osteoclastic bone resorption in excess of osteoblastic bone formation, resulting in osteoporosis. We found that oral administration of\n                    <jats:italic>Artemisia annua<\/jats:italic>\n                    ethanol extract (AaE) or major components, artemisinin and arteannuin B, to ovariectomized (OVX) mice prevented bone loss, as verified by examining three-dimensional images and bone morphometric parameters derived from microcomputed tomography analysis, as well as serum levels of bone turnover markers and proinflammatory cytokines. The administered doses were not toxic to the liver or kidney and showed promising effects that were comparable to those of 17\u03b2-estradiol treatment. At non-cytotoxic concentrations, AaE and active components, artemisinin, artemisinic acid, and arteannuin B, potently inhibited receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclastogenesis and the formation of osteoclast-mediated resorption pits. Furthermore, AaE, artemisinin, and arteannuin B remarkably reduced the expression of the c-Fos and NFATc1 transcription factors, which play critical roles in RANKL-induced osteoclast differentiation. Taken together, the\n                    <jats:italic>in vivo<\/jats:italic>\n                    anti-osteoporotic activity of AaE may be derived from the anti-osteoclastic and anti-bone resorptive activities of its active components. AaE has beneficial applications for the prevention and inhibition of osteoporosis and osteoclast-mediated bone diseases.\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-17427-6","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T09:30:56Z","timestamp":1512466256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Artemisia annua extract prevents ovariectomy-induced bone loss by blocking receptor activator of nuclear factor kappa-B ligand-induced differentiation of osteoclasts"],"prefix":"10.1038","volume":"7","author":[{"given":"Sun Kyoung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyungkeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Rim","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hwa","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Kyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8428-9005","authenticated-orcid":false,"given":"Won-Yoon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"key":"17427_CR1","doi-asserted-by":"publisher","first-page":"25103","DOI":"10.1074\/jbc.R109.041087","volume":"285","author":"LJ Raggatt","year":"2010","unstructured":"Raggatt, L. J. & Partridge, N. C. Cellular and molecular mechanisms of bone remodeling. J. Biol. Chem. 285, 25103\u201325108 (2010).","journal-title":"J. Biol. Chem."},{"key":"17427_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle, W. J., Simonet, W. S. & Lacey, D. L. Osteoclast differentiation and activation. Nature 423, 337\u2013342 (2003).","journal-title":"Nature"},{"key":"17427_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature01660","volume":"423","author":"S Harada","year":"2003","unstructured":"Harada, S. & Rodan, G. A. Control of osteoblast function and regulation of bone mass. Nature 423, 349\u2013355 (2003).","journal-title":"Nature"},{"key":"17427_CR4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm1593","volume":"13","author":"M Zaidi","year":"2007","unstructured":"Zaidi, M. Skeletal remodeling in health and disease. Nat. Med. 13, 791\u2013801 (2007).","journal-title":"Nat. Med."},{"key":"17427_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cytogfr.2004.06.004","volume":"15","author":"S Theoleyre","year":"2004","unstructured":"Theoleyre, S. et al. The molecular triad OPG\/RANK\/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev. 15, 457\u2013475 (2004).","journal-title":"Cytokine Growth Factor Rev."},{"key":"17427_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cger.2005.02.002","volume":"21","author":"LS Simon","year":"2005","unstructured":"Simon, L. S. Osteoporosis. Clin. Geriatr, Med. 21, 603\u2013629 (2005).","journal-title":"Clin. Geriatr, Med."},{"key":"17427_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semcdb.2015.10.013","volume":"49","author":"AT Shaw","year":"2016","unstructured":"Shaw, A. T. & Gravallese, E. M. Mediators of inflammation and bone remodeling in rheumatic disease. Semin. Cell Dev. Biol. 49, 2\u201310 (2016).","journal-title":"Semin. Cell Dev. Biol."},{"key":"17427_CR8","first-page":"584","volume":"2","author":"GR Mundy","year":"2002","unstructured":"Mundy, G. R. Metastasis to bone: causes, consequences and therapeutic opportunities. Nature Rev. Cancer 2, 584\u2013593 (2002).","journal-title":"Cancer"},{"key":"17427_CR9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/nu8060376","volume":"8","author":"MC Kruger","year":"2016","unstructured":"Kruger, M. C. & Wolber, F. M. Osteoporosis: Modern Paradigms for Last Century\u2019s Bones. Nutrients 8, 376, https:\/\/doi.org\/10.3390\/nu8060376 (2016).","journal-title":"Nutrients"},{"key":"17427_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.maturitas.2010.01.002","volume":"65","author":"JC Gallagher","year":"2010","unstructured":"Gallagher, J. C. & Sai, A. J. Molecular biology of bone remodeling: implications for new therapeutic targets for osteoporosis. Maturitas 65, 301\u2013307 (2010).","journal-title":"Maturitas"},{"key":"17427_CR11","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/sj.bjc.6604382","volume":"98","author":"RE Coleman","year":"2008","unstructured":"Coleman, R. E. Risks and benefits of bisphosphonates. Br. J. Cancer 98, 1736\u20131740 (2008).","journal-title":"Br. J. Cancer"},{"key":"17427_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.11005\/jbm.2014.21.2.155","volume":"21","author":"Y Won","year":"2014","unstructured":"Won, Y., Lim, J. R., Kim, Y. H., Song, H. K. & Yang, K. H. Atypical femoral fracture combined with osteonecrosis of jaw during osteoporosis treatment with bisphosphonate. J. Bone Metab. 21, 155\u2013159 (2014).","journal-title":"J. Bone Metab."},{"key":"17427_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/ncpendmet0325","volume":"2","author":"JE Mulder","year":"2006","unstructured":"Mulder, J. E., Kolatkar, N. S. & LeBoff, M. S. Drug insight: Existing and emerging therapies for osteoporosis. Nat. Clin. Pract. Endocrinol. Metab. 2, 670\u2013680 (2006).","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"17427_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/TCRM.S24239","volume":"8","author":"AD Anastasilakis","year":"2012","unstructured":"Anastasilakis, A. D., Toulis, K. A., Polyzos, S. A., Anastasilakis, C. D. & Makras, P. Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab. Ther. Clin. Risk Manag. 8, 295\u2013306 (2012).","journal-title":"Ther. Clin. Risk Manag."},{"key":"17427_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00223-015-0050-1","volume":"98","author":"P Esbrit","year":"2016","unstructured":"Esbrit, P., Herrera, S., Portal-Nunez, S., Nogues, X. & Diez-Perez, A. Parathyroid Hormone-Related Protein Analogs as Osteoporosis Therapies. Calcif. Tissue Int. 98, 359\u2013369 (2016).","journal-title":"Calcif. Tissue Int."},{"key":"17427_CR16","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","volume":"48","author":"R Baron","year":"2011","unstructured":"Baron, R., Ferrari, S. & Russell, R. G. Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 48, 677\u2013692 (2011).","journal-title":"Bone"},{"key":"17427_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/0974-8520.100295","volume":"33","author":"C Katiyar","year":"2012","unstructured":"Katiyar, C., Gupta, A., Kanjilal, S. & Katiyar, S. Drug discovery from plant sources: An integrated approach. Ayu 33, 10\u201319 (2012).","journal-title":"Ayu"},{"key":"17427_CR18","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","volume":"1830","author":"GM Cragg","year":"2013","unstructured":"Cragg, G. M. & Newman, D. J. Natural products: a continuing source of novel drug leads. Biochim. Biophys. Acta 1830, 3670\u20133695 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"17427_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep12853","volume":"5","author":"S Chen","year":"2015","unstructured":"Chen, S. et al. Lycorine suppresses RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced osteoporosis and titanium particle-induced osteolysis in vivo. Sci. Rep. 5, 12853 (2015).","journal-title":"Sci. Rep."},{"key":"17427_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep17605","volume":"5","author":"J Li","year":"2015","unstructured":"Li, J. et al. Inhibition of Osteoclastogenesis and Bone Resorption in vitro and in vivo by a prenylflavonoid xanthohumol from hops. Sci. Rep. 5, 17605 (2015).","journal-title":"Sci. Rep."},{"key":"17427_CR21","first-page":"4573","volume":"3","author":"S Das","year":"2012","unstructured":"Das, S. ARTEMISIA ANNUA (QINGHAO): A Pharmacological Review. Int. J. Pharm. Sci. Res. 3, 4573\u20134577 (2012).","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"17427_CR22","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.3390\/molecules15053135","volume":"15","author":"JF Ferreira","year":"2010","unstructured":"Ferreira, J. F., Luthria, D. L., Sasaki, T. & Heyerick, A. Flavonoids from Artemisia annua L. as antioxidants and their potential synergism with artemisinin against malaria and cancer. Molecules 15, 3135\u20133170 (2010).","journal-title":"Molecules"},{"key":"17427_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2013.08.021","volume":"150","author":"F van der Kooy","year":"2013","unstructured":"van der Kooy, F. & Sullivan, S. E. The complexity of medicinal plants: the traditional Artemisia annua formulation, current status and future perspectives. J. Ethnopharmacol. 150, 1\u201313 (2013).","journal-title":"J. Ethnopharmacol."},{"key":"17427_CR24","doi-asserted-by":"crossref","first-page":"159819","DOI":"10.1155\/2014\/159819","volume":"2014","author":"AR Bilia","year":"2014","unstructured":"Bilia, A. R., Santomauro, F., Sacco, C., Bergonzi, M. C. & Donato, R. Essential Oil of Artemisia annua L.: An Extraordinary Component with Numerous Antimicrobial Properties. Evid. Based Complement Alternat. Med. 2014, 159819 (2014).","journal-title":"Evid. Based Complement Alternat. Med."},{"key":"17427_CR25","first-page":"539","volume":"11","author":"DI Hwang","year":"2016","unstructured":"Hwang, D. I. et al. Anti-adipocyte Differentiation Activity and Chemical Composition of Essential Oil from Artemisia annua. Nat. Prod. Commun. 11, 539\u2013542 (2016).","journal-title":"Nat. Prod. Commun."},{"key":"17427_CR26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1089\/jmf.2015.3527","volume":"19","author":"KE Kim","year":"2016","unstructured":"Kim, K. E. et al. Artemisia annua Leaf Extract Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet-Fed Mice. J. Med. Food 19, 290\u2013299 (2016).","journal-title":"J. Med. Food"},{"key":"17427_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1039\/B816679J","volume":"39","author":"D Chaturvedi","year":"2010","unstructured":"Chaturvedi, D., Goswami, A., Saikia, P. P., Barua, N. C. & Rao, P. G. Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents. Chem. Soc. Rev. 39, 435\u2013454 (2010).","journal-title":"Chem. Soc. Rev."},{"key":"17427_CR28","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1517\/13543776.2012.724063","volume":"22","author":"NM Njuguna","year":"2012","unstructured":"Njuguna, N. M., Ongarora, D. S. & Chibale, K. Artemisinin derivatives: a patent review (2006 - present). Expert Opin. Ther. Pat. 22, 1179\u20131203 (2012).","journal-title":"Expert Opin. Ther. Pat."},{"key":"17427_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","volume":"142","author":"WE Ho","year":"2014","unstructured":"Ho, W. E., Peh, H. Y., Chan, T. K. & Wong, W. S. Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol. Ther. 142, 126\u2013139 (2014).","journal-title":"Pharmacol. Ther."},{"key":"17427_CR30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","volume":"31","author":"HC Lai","year":"2013","unstructured":"Lai, H. C., Singh, N. P. & Sasaki, T. Development of artemisinin compounds for cancer treatment. Invest. New Drugs 31, 230\u2013246 (2013).","journal-title":"Invest. New Drugs"},{"key":"17427_CR31","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1172\/JCI28550","volume":"116","author":"MN Weitzmann","year":"2006","unstructured":"Weitzmann, M. N. & Pacifici, R. Estrogen deficiency and bone loss: an inflammatory tale. The J. Clin. Invest. 116, 1186\u20131194 (2006).","journal-title":"The J. Clin. Invest."},{"key":"17427_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1055\/s-2000-11115","volume":"66","author":"TE Wallaart","year":"2000","unstructured":"Wallaart, T. E., Pras, N., Beekman, A. C. & Quax, W. J. Seasonal variation of artemisinin and its biosynthetic precursors in plants of Artemisia annua of different geographical origin: proof for the existence of chemotypes. Planta Med. 66, 57\u201362 (2000).","journal-title":"Planta Med."},{"key":"17427_CR33","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.bbrc.2004.11.077","volume":"328","author":"HC Blair","year":"2005","unstructured":"Blair, H. C., Robinson, L. J. & Zaidi, M. Osteoclast signalling pathways. Biochem. Biophys. Res. Commun. 328, 728\u2013738 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"17427_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","volume":"40","author":"M Asagiri","year":"2007","unstructured":"Asagiri, M. & Takayanagi, H. The molecular understanding of osteoclast differentiation. Bone 40, 251\u2013264 (2007).","journal-title":"Bone"},{"key":"17427_CR35","doi-asserted-by":"publisher","first-page":"18245","DOI":"10.1074\/jbc.M610701200","volume":"282","author":"T Yamashita","year":"2007","unstructured":"Yamashita, T. et al. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J. Biol. Chem. 282, 18245\u201318253 (2007).","journal-title":"J. Biol. Chem."},{"key":"17427_CR36","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1301\/nr.2007.dec.S147-S151","volume":"65","author":"GR Mundy","year":"2007","unstructured":"Mundy, G. R. Osteoporosis and inflammation. Nutr. Rev. 65, S147\u2013151 (2007).","journal-title":"Nutr. Rev."},{"key":"17427_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2174\/1568010054022015","volume":"4","author":"Y Tanaka","year":"2005","unstructured":"Tanaka, Y., Nakayamada, S. & Okada, Y. Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets Inflamm. Allergy 4, 325\u2013328 (2005).","journal-title":"Curr Drug Targets Inflamm. Allergy"},{"key":"17427_CR38","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7150\/ijms.5180","volume":"9","author":"R Zhao","year":"2012","unstructured":"Zhao, R. Immune regulation of osteoclast function in postmenopausal osteoporosis: a critical interdisciplinary perspective. Int. J. Med. Sci. 9, 825\u2013832 (2012).","journal-title":"Int. J. Med. Sci."},{"key":"17427_CR39","doi-asserted-by":"crossref","unstructured":"Nguyen, K. T., Towler, M. J. & Weathers, P. J. The effect of roots and media constituents on trichomes and artemisinin production in Artemisia annua L. Plant Cell Rep. 32, 207\u2013218 (2013).","DOI":"10.1007\/s00299-012-1355-4"},{"key":"17427_CR40","doi-asserted-by":"publisher","first-page":"e80790","DOI":"10.1371\/journal.pone.0080790","volume":"8","author":"JO Suberu","year":"2013","unstructured":"Suberu, J. O. et al. Anti-plasmodial polyvalent interactions in Artemisia annua L. aqueous extract\u2013possible synergistic and resistance mechanisms. PLoS One 8, e80790 (2013).","journal-title":"PLoS One"},{"key":"17427_CR41","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jpba.2013.06.025","volume":"84","author":"J Suberu","year":"2013","unstructured":"Suberu, J. et al. A rapid method for the determination of artemisinin and its biosynthetic precursors in Artemisia annua L. crude extracts. J. Pharm. Biomed. Anal. 84, 269\u2013277 (2013).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"17427_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/srep21499","volume":"6","author":"C Dou","year":"2016","unstructured":"Dou, C. et al. Changing expression profiles of lncRNAs, mRNAs, circRNAs and miRNAs during osteoclastogenesis. Sci. Rep. 6, 21499 (2016).","journal-title":"Sci. Rep."},{"key":"17427_CR43","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","volume":"3","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889\u2013901 (2002).","journal-title":"Dev. Cell"},{"key":"17427_CR44","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.abb.2014.07.034","volume":"561","author":"KB Paiva","year":"2014","unstructured":"Paiva, K. B. & Granjeiro, J. M. Bone tissue remodeling and development: focus on matrix metalloproteinase functions. Arch. Biochem. Biophys. 561, 74\u201387 (2014).","journal-title":"Arch. Biochem. Biophys."},{"key":"17427_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bcp.2016.04.010","volume":"117","author":"K Mukherjee","year":"2016","unstructured":"Mukherjee, K. & Chattopadhyay, N. Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy. Biochem. Pharmacol. 117, 10\u201319 (2016).","journal-title":"Biochem. Pharmacol."},{"key":"17427_CR46","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1677\/JOE-08-0568","volume":"201","author":"R Hardy","year":"2009","unstructured":"Hardy, R. & Cooper, M. S. Bone loss in inflammatory disorders. J. Endocrinol. 201, 309\u2013320 (2009).","journal-title":"J. Endocrinol."},{"key":"17427_CR47","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1002\/ptr.4930","volume":"27","author":"SK Lee","year":"2013","unstructured":"Lee, S. K., Park, K. K., Park, J. H., Lim, S. S. & Chung, W. Y. The inhibitory effect of roasted licorice extract on human metastatic breast cancer cell-induced bone destruction. Phytother. Res. 27, 1776\u20131783 (2013).","journal-title":"Phytother. Res."},{"key":"17427_CR48","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/path.4597","volume":"237","author":"HJ Kim","year":"2015","unstructured":"Kim, H. J. et al. Loss of RUNX3 expression promotes cancer-associated bone destruction by regulating CCL5, CCL19 and CXCL11 in non-small cell lung cancer. J. Pathol. 237, 520\u2013531 (2015).","journal-title":"J. Pathol."},{"key":"17427_CR49","doi-asserted-by":"publisher","first-page":"e0122764","DOI":"10.1371\/journal.pone.0122764","volume":"10","author":"KR Kim","year":"2015","unstructured":"Kim, K. R. et al. 15-deoxy-delta12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. PloS one 10, e0122764 (2015).","journal-title":"PloS one"},{"key":"17427_CR50","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1159\/000430152","volume":"36","author":"SK Lee","year":"2015","unstructured":"Lee, S. K. et al. Platycodin D Blocks Breast Cancer-Induced Bone Destruction by Inhibiting Osteoclastogenesis and the Growth of Breast Cancer Cells. Cell. Physiol. Biochem. 36, 1809\u20131820 (2015).","journal-title":"Cell. Physiol. Biochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17427-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17427-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17427-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T23:19:40Z","timestamp":1751066380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17427-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["17427"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-17427-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,11]]},"assertion":[{"value":"14 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17332"}}